Acrodermatitis chronica atrophicans: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(7 intermediate revisions by 5 users not shown)
Line 2: Line 2:
'''For patient information, click [[Acrodermatitis chronica atrophicans (patient information)|here]]'''
'''For patient information, click [[Acrodermatitis chronica atrophicans (patient information)|here]]'''
{{ACA}}
{{ACA}}
{{CMG}}; {{AE}} {{RT}}
{{CMG}}; {{AE}} {{Anahita}} {{RT}}


{{SK}}  Pick-Herxheimer disease; ACA
{{SK}}  Pick-Herxheimer disease; Herxheimer disease; primary diffuse atrophy; ACA


==[[Acrodermatitis chronica atrophicans overview|Overview]]==
==[[Acrodermatitis chronica atrophicans overview|Overview]]==
==[[Acrodermatitis chronica atrophicans historical perspective|Historical Perspective]]==
==[[Acrodermatitis chronica atrophicans historical perspective|Historical Perspective]]==
==[[Acrodermatitis chronica atrophicans classification|Classification]]==
==[[Acrodermatitis chronica atrophicans pathophysiology|Pathophysiology]]==
==[[Acrodermatitis chronica atrophicans pathophysiology|Pathophysiology]]==
==[[Acrodermatitis chronica atrophicans causes|Causes]]==
==[[Acrodermatitis chronica atrophicans causes|Causes]]==
==[[Acrodermatitis chronica atrophicans differential diagnosis|Differentiating Acrodermatitis chronica atrophicans from other Diseases]]==
==[[Acrodermatitis chronica atrophicans differential diagnosis|Differentiating Acrodermatitis chronica atrophicans from other Diseases]]==
==[[Acrodermatitis chronica atrophicans epidemiology and demographics|Epidemiology and Demographics]]==
==[[Acrodermatitis chronica atrophicans epidemiology and demographics|Epidemiology and Demographics]]==
==[[Acrodermatitis chronica atrophicans risk factors|Risk Factors]]==
==[[Acrodermatitis chronica atrophicans risk factors|Risk Factors]]==
==[[Acrodermatitis chronica atrophicans screening|Screening]]==
==[[Acrodermatitis_chronica_atrophicans_natural_history,_complications_and_prognosis|Natural History, Complications and Prognosis]]==
==[[Acrodermatitis_chronica_atrophicans_natural_history,_complications_and_prognosis|Natural History, Complications, and Prognosis]]==
 
==Diagnosis==
==Diagnosis==
[[Acrodermatitis chronica atrophicans history and symptoms|History and Symptoms]] | [[Acrodermatitis chronica atrophicans physical examination|Physical Examination]] | [[Acrodermatitis chronica atrophicans laboratory findings|Laboratory Findings]] | [[Acrodermatitis chronica atrophicans x ray|X Ray]] | [[Acrodermatitis chronica atrophicans CT|CT]] | [[Acrodermatitis chronica atrophicans MRI|MRI]] | [[Acrodermatitis chronica atrophicans ultrasound|Ultrasound]] | [[Acrodermatitis chronica atrophicans other imaging findings|Other Imaging Findings]] | [[Acrodermatitis chronica atrophicans other diagnostic studies|Other Diagnostic Studies]]
[[Acrodermatitis chronica atrophicans history and symptoms|History and Symptoms]] | [[Acrodermatitis chronica atrophicans physical examination|Physical Examination]] | [[Acrodermatitis chronica atrophicans laboratory findings|Laboratory Findings]] | [[Acrodermatitis chronica atrophicans other diagnostic studies|Other Diagnostic Studies]]
==Treatment==
==Treatment==
[[Acrodermatitis chronica atrophicans medical therapy|Medical Therapy]] | [[Acrodermatitis chronica atrophicans surgery|Surgery]] | [[Acrodermatitis chronica atrophicans primary prevention|Primary Prevention]] | [[Acrodermatitis chronica atrophicans secondary prevention|Secondary Prevention]] | [[Acrodermatitis chronica atrophicans cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Acrodermatitis chronica atrophicans future or investigational therapies|Future or Investigational Therapies]]
[[Acrodermatitis chronica atrophicans medical therapy|Medical Therapy]] | [[Acrodermatitis chronica atrophicans primary prevention|Primary Prevention]] | [[Acrodermatitis chronica atrophicans secondary prevention|Secondary Prevention]] | [[Acrodermatitis chronica atrophicans cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Acrodermatitis chronica atrophicans future or investigational therapies|Future or Investigational Therapies]]


==Case Studies==
==Case Studies==
Line 36: Line 34:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Dermatology]]
[[Category:Dermatology]]
[[Category:Symptoms]]
[[Category:Insect-borne diseases]]
[[Category:Insect-borne diseases]]
[[Category:Lyme disease]]
[[Category:Lyme disease]]
[[Category:Zoonoses]]
[[Category:Zoonoses]]
[[Category:Spirochaetes]]
[[Category:Spirochaetes]]
[[Category:Infectious disease]]

Latest revision as of 07:54, 4 August 2022

For patient information, click here

Acrodermatitis chronica atrophicans Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Acrodermatitis chronica atrophicans from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acrodermatitis chronica atrophicans On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acrodermatitis chronica atrophicans

CDC on Acrodermatitis chronica atrophicans

Acrodermatitis chronica atrophicans in the news

Blogs on Acrodermatitis chronica atrophicans

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Acrodermatitis chronica atrophicans

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2] Raviteja Guddeti, M.B.B.S. [3]

Synonyms and keywords: Pick-Herxheimer disease; Herxheimer disease; primary diffuse atrophy; ACA

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Acrodermatitis chronica atrophicans from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters

References